dr. Jarir At Thobari, D.Pharm., Ph.

Curriculum Vitae
EMAIL:

j.atthobari@gmail.com / j.atthobari@ugm.ac.id

PENDIDIKAN:

● S1 : Fakultas Kedokteran, Universitas Gadjah Mada Yogyakarta (1997)

● S2 :Master Program in Hospital Management, University of New South Wales
(UNSW), Australia (1993)
● S3 : Doctorate Degree (PhD) at Department of Pharmaco-epidemiology,
Pharmacoeconomy and Pharmaco-therapy. Groningen University Institute for
Drugs Exploration (GUIDE), Groningen University, the Netherlands (2006)
MINAT PENELITIAN:

Farmakologi, Farmakoekonomi

PENELITIAN:

1. Effectiveness of rotavirus vaccine RV3 Biofarma in Indonesia. 2023.

2. Cost-effectiveness of Dengue Vaccine in Indonesia (Study coordinator). 2023.
3. CT Efficacy and Safety Biosimilar Enoxaparin for Acute Coronary Syndrome (Trial
Coordinator). 2023.
4. Cost-effectiveness of Typhoid Conjugated Vaccine in Indonesia (Study
coordinator). 2022-now.
5. CT efficacy and safety Advagene Nasal Spray in COVID-19 patients. 2022-now.
6. CT Immunogenicity and Safety COVID-19 Vaccine Indovac for Children aged
12-18 years old (Trial Coordinator). 2022-now.
7. CT Immunogenicity and Safety Booster Vaccine Sinopharm Homologous and
Heterologous (Trial Coordinator). 2022-now.
8. CT Adimmune COVID Vaccine phase 1/2 trial (Trial Coordinator). 2022-now.
9. Knowledge and Acceptability of Dengue Vaccine in Indonesia. 2022-now.
10. Safety & Effectiveness Vaccine Sinopharm (coordinating investigator).
2021-2022.
11. CT Rotavirus Vaccine Phase III (Trial Coordinator). 2020-now.
12. Cost Effectiveness of Rotavirus Vaccine (PI). 2020-2022.
dr. Jarir At Thobari, D.Pharm., Ph.D
13. Safety & effectiveness Favipiravir & Remdesivir (coordinating investigator).
2021-2022.
14. CT Stem cell for COVID-19 (member). 2020-2022.
15. CT Plasma Convalescent for COVID19 (Lead Investigator). 2020-2021.